NCT02100943View on ClinicalTrials.gov

Exhaled NO as a Biomarker of Gestational OSA and Persistence Postpartum

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

November 14, 2016

Study Completion Date

November 14, 2016

Conditions
PregnancyOSA
Trial Locations (1)

27157

Wake Forest School of Medicine, Forsyth Medical Center, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT02100943 - Exhaled NO as a Biomarker of Gestational OSA and Persistence Postpartum | Biotech Hunter | Biotech Hunter